nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP2D6—Fingolimod—multiple sclerosis	0.052	0.231	CbGbCtD
Mianserin—HTR1D—trigeminal nucleus—multiple sclerosis	0.0415	0.156	CbGeAlD
Mianserin—CYP3A4—Fingolimod—multiple sclerosis	0.0331	0.147	CbGbCtD
Mianserin—HTR1D—meninx—multiple sclerosis	0.0275	0.104	CbGeAlD
Mianserin—HTR1F—trigeminal nerve—multiple sclerosis	0.0275	0.103	CbGeAlD
Mianserin—CYP2B6—Dexamethasone—multiple sclerosis	0.0262	0.116	CbGbCtD
Mianserin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0213	0.0945	CbGbCtD
Mianserin—HTR2A—trigeminal nucleus—multiple sclerosis	0.0206	0.0776	CbGeAlD
Mianserin—CYP3A4—Triamcinolone—multiple sclerosis	0.0161	0.0716	CbGbCtD
Mianserin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0155	0.0689	CbGbCtD
Mianserin—CYP3A4—Betamethasone—multiple sclerosis	0.0139	0.0615	CbGbCtD
Mianserin—CYP3A4—Prednisolone—multiple sclerosis	0.0137	0.0606	CbGbCtD
Mianserin—CYP3A4—Prednisone—multiple sclerosis	0.0129	0.0573	CbGbCtD
Mianserin—CYP2D6—Dexamethasone—multiple sclerosis	0.0127	0.0562	CbGbCtD
Mianserin—HTR1D—trigeminal nerve—multiple sclerosis	0.0109	0.041	CbGeAlD
Mianserin—CYP3A4—Dexamethasone—multiple sclerosis	0.00806	0.0357	CbGbCtD
Mianserin—HTR7—pons—multiple sclerosis	0.00611	0.023	CbGeAlD
Mianserin—HTR2A—trigeminal nerve—multiple sclerosis	0.00541	0.0204	CbGeAlD
Mianserin—SLC6A3—nerve—multiple sclerosis	0.00408	0.0154	CbGeAlD
Mianserin—HTR7—peripheral nervous system—multiple sclerosis	0.00407	0.0153	CbGeAlD
Mianserin—HTR2A—pons—multiple sclerosis	0.00381	0.0144	CbGeAlD
Mianserin—SLC6A2—nerve—multiple sclerosis	0.00329	0.0124	CbGeAlD
Mianserin—HTR7—nerve—multiple sclerosis	0.00317	0.0119	CbGeAlD
Mianserin—DRD2—nerve—multiple sclerosis	0.003	0.0113	CbGeAlD
Mianserin—ADRA2A—peripheral nervous system—multiple sclerosis	0.00298	0.0112	CbGeAlD
Mianserin—HTR2A—pineal body—multiple sclerosis	0.00272	0.0102	CbGeAlD
Mianserin—HTR2A—peripheral nervous system—multiple sclerosis	0.00254	0.00955	CbGeAlD
Mianserin—HTR1F—nervous system—multiple sclerosis	0.00226	0.0085	CbGeAlD
Mianserin—HTR1F—central nervous system—multiple sclerosis	0.00217	0.00818	CbGeAlD
Mianserin—HTR2A—nerve—multiple sclerosis	0.00198	0.00744	CbGeAlD
Mianserin—SLC6A3—brainstem—multiple sclerosis	0.00175	0.00659	CbGeAlD
Mianserin—HTR1F—brain—multiple sclerosis	0.00173	0.00649	CbGeAlD
Mianserin—HTR1D—brainstem—multiple sclerosis	0.00171	0.00643	CbGeAlD
Mianserin—HTR2C—brainstem—multiple sclerosis	0.00169	0.00637	CbGeAlD
Mianserin—SLC6A4—brainstem—multiple sclerosis	0.0016	0.00604	CbGeAlD
Mianserin—DRD3—nervous system—multiple sclerosis	0.00159	0.006	CbGeAlD
Mianserin—DRD3—central nervous system—multiple sclerosis	0.00153	0.00578	CbGeAlD
Mianserin—HTR6—nervous system—multiple sclerosis	0.00153	0.00578	CbGeAlD
Mianserin—HTR6—central nervous system—multiple sclerosis	0.00148	0.00556	CbGeAlD
Mianserin—HTR1A—brainstem—multiple sclerosis	0.00142	0.00536	CbGeAlD
Mianserin—OPRK1—nervous system—multiple sclerosis	0.00142	0.00535	CbGeAlD
Mianserin—SLC6A2—brainstem—multiple sclerosis	0.00141	0.00532	CbGeAlD
Mianserin—HRH2—nervous system—multiple sclerosis	0.0014	0.00528	CbGeAlD
Mianserin—OPRK1—central nervous system—multiple sclerosis	0.00137	0.00515	CbGeAlD
Mianserin—HTR7—brainstem—multiple sclerosis	0.00136	0.00512	CbGeAlD
Mianserin—HRH2—central nervous system—multiple sclerosis	0.00135	0.00508	CbGeAlD
Mianserin—OPRK1—cerebellum—multiple sclerosis	0.00134	0.00503	CbGeAlD
Mianserin—DRD2—brainstem—multiple sclerosis	0.00129	0.00484	CbGeAlD
Mianserin—DRD2—retina—multiple sclerosis	0.00124	0.00467	CbGeAlD
Mianserin—DRD3—brain—multiple sclerosis	0.00122	0.00459	CbGeAlD
Mianserin—HTR2C—medulla oblongata—multiple sclerosis	0.00118	0.00444	CbGeAlD
Mianserin—HTR6—brain—multiple sclerosis	0.00117	0.00441	CbGeAlD
Mianserin—SLC6A3—midbrain—multiple sclerosis	0.00112	0.0042	CbGeAlD
Mianserin—HTR1D—midbrain—multiple sclerosis	0.00109	0.0041	CbGeAlD
Mianserin—SLC6A3—spinal cord—multiple sclerosis	0.00109	0.0041	CbGeAlD
Mianserin—OPRK1—brain—multiple sclerosis	0.00109	0.00409	CbGeAlD
Mianserin—HTR2C—midbrain—multiple sclerosis	0.00108	0.00406	CbGeAlD
Mianserin—HRH2—brain—multiple sclerosis	0.00107	0.00404	CbGeAlD
Mianserin—HTR2C—spinal cord—multiple sclerosis	0.00105	0.00396	CbGeAlD
Mianserin—SLC6A4—midbrain—multiple sclerosis	0.00102	0.00385	CbGeAlD
Mianserin—SLC6A4—spinal cord—multiple sclerosis	0.000997	0.00376	CbGeAlD
Mianserin—SLC6A2—medulla oblongata—multiple sclerosis	0.000985	0.00371	CbGeAlD
Mianserin—HTR7—medulla oblongata—multiple sclerosis	0.000949	0.00357	CbGeAlD
Mianserin—SLC6A3—nervous system—multiple sclerosis	0.000917	0.00345	CbGeAlD
Mianserin—Somnolence—Cladribine—multiple sclerosis	0.000915	0.00357	CcSEcCtD
Mianserin—HTR1A—midbrain—multiple sclerosis	0.000908	0.00342	CbGeAlD
Mianserin—Cardiac arrest—Betamethasone—multiple sclerosis	0.000896	0.00349	CcSEcCtD
Mianserin—Cardiac arrest—Dexamethasone—multiple sclerosis	0.000896	0.00349	CcSEcCtD
Mianserin—HTR1D—nervous system—multiple sclerosis	0.000895	0.00337	CbGeAlD
Mianserin—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000889	0.00346	CcSEcCtD
Mianserin—Weight increased—Prednisolone—multiple sclerosis	0.000889	0.00346	CcSEcCtD
Mianserin—Fatigue—Cladribine—multiple sclerosis	0.000888	0.00346	CcSEcCtD
Mianserin—HTR2C—nervous system—multiple sclerosis	0.000886	0.00334	CbGeAlD
Mianserin—HTR1A—spinal cord—multiple sclerosis	0.000886	0.00333	CbGeAlD
Mianserin—SLC6A3—central nervous system—multiple sclerosis	0.000883	0.00332	CbGeAlD
Mianserin—Constipation—Cladribine—multiple sclerosis	0.00088	0.00343	CcSEcCtD
Mianserin—Arthralgia—Azathioprine—multiple sclerosis	0.000873	0.0034	CcSEcCtD
Mianserin—Myalgia—Azathioprine—multiple sclerosis	0.000873	0.0034	CcSEcCtD
Mianserin—ADRA2C—medulla oblongata—multiple sclerosis	0.000872	0.00328	CbGeAlD
Mianserin—HTR7—midbrain—multiple sclerosis	0.000867	0.00327	CbGeAlD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000867	0.00338	CcSEcCtD
Mianserin—SLC6A3—cerebellum—multiple sclerosis	0.000863	0.00325	CbGeAlD
Mianserin—HTR1D—central nervous system—multiple sclerosis	0.000862	0.00325	CbGeAlD
Mianserin—HTR2C—central nervous system—multiple sclerosis	0.000853	0.00321	CbGeAlD
Mianserin—HTR2A—brainstem—multiple sclerosis	0.000849	0.0032	CbGeAlD
Mianserin—Feeling abnormal—Cladribine—multiple sclerosis	0.000848	0.0033	CcSEcCtD
Mianserin—HTR7—spinal cord—multiple sclerosis	0.000846	0.00319	CbGeAlD
Mianserin—Gynaecomastia—Methotrexate—multiple sclerosis	0.000846	0.00329	CcSEcCtD
Mianserin—Cardiac failure—Prednisone—multiple sclerosis	0.000841	0.00328	CcSEcCtD
Mianserin—SLC6A4—nervous system—multiple sclerosis	0.00084	0.00316	CbGeAlD
Mianserin—Lethargy—Prednisone—multiple sclerosis	0.000838	0.00326	CcSEcCtD
Mianserin—HTR2B—nervous system—multiple sclerosis	0.000833	0.00314	CbGeAlD
Mianserin—DRD2—midbrain—multiple sclerosis	0.00082	0.00309	CbGeAlD
Mianserin—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00082	0.00319	CcSEcCtD
Mianserin—HTR2A—retina—multiple sclerosis	0.000819	0.00308	CbGeAlD
Mianserin—Weight increased—Triamcinolone—multiple sclerosis	0.000817	0.00318	CcSEcCtD
Mianserin—Weight increased—Methylprednisolone—multiple sclerosis	0.000815	0.00318	CcSEcCtD
Mianserin—Skin disorder—Azathioprine—multiple sclerosis	0.000813	0.00317	CcSEcCtD
Mianserin—SLC6A4—central nervous system—multiple sclerosis	0.000809	0.00305	CbGeAlD
Mianserin—HTR2B—central nervous system—multiple sclerosis	0.000802	0.00302	CbGeAlD
Mianserin—ADRA2C—midbrain—multiple sclerosis	0.000797	0.003	CbGeAlD
Mianserin—Bradycardia—Prednisolone—multiple sclerosis	0.000796	0.0031	CcSEcCtD
Mianserin—Hypotension—Azathioprine—multiple sclerosis	0.000782	0.00305	CcSEcCtD
Mianserin—Cardiac arrest—Prednisone—multiple sclerosis	0.000781	0.00304	CcSEcCtD
Mianserin—ADRA2C—spinal cord—multiple sclerosis	0.000778	0.00293	CbGeAlD
Mianserin—CYP2D6—brainstem—multiple sclerosis	0.000773	0.00291	CbGeAlD
Mianserin—Anaemia—Mitoxantrone—multiple sclerosis	0.000766	0.00299	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000763	0.00297	CcSEcCtD
Mianserin—HTR1A—nervous system—multiple sclerosis	0.000746	0.00281	CbGeAlD
Mianserin—Leukopenia—Mitoxantrone—multiple sclerosis	0.000742	0.00289	CcSEcCtD
Mianserin—Weight increased—Dexamethasone—multiple sclerosis	0.000741	0.00289	CcSEcCtD
Mianserin—Weight increased—Betamethasone—multiple sclerosis	0.000741	0.00289	CcSEcCtD
Mianserin—SLC6A2—nervous system—multiple sclerosis	0.00074	0.00279	CbGeAlD
Mianserin—Asthenia—Cladribine—multiple sclerosis	0.000739	0.00288	CcSEcCtD
Mianserin—Bradycardia—Triamcinolone—multiple sclerosis	0.000732	0.00285	CcSEcCtD
Mianserin—Bradycardia—Methylprednisolone—multiple sclerosis	0.00073	0.00284	CcSEcCtD
Mianserin—Pruritus—Cladribine—multiple sclerosis	0.000728	0.00284	CcSEcCtD
Mianserin—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000723	0.00282	CcSEcCtD
Mianserin—Convulsion—Mitoxantrone—multiple sclerosis	0.000718	0.0028	CcSEcCtD
Mianserin—HTR1A—central nervous system—multiple sclerosis	0.000718	0.0027	CbGeAlD
Mianserin—Hypertension—Mitoxantrone—multiple sclerosis	0.000716	0.00279	CcSEcCtD
Mianserin—HTR7—nervous system—multiple sclerosis	0.000713	0.00268	CbGeAlD
Mianserin—SLC6A2—central nervous system—multiple sclerosis	0.000712	0.00268	CbGeAlD
Mianserin—Myalgia—Mitoxantrone—multiple sclerosis	0.000706	0.00275	CcSEcCtD
Mianserin—Arthralgia—Mitoxantrone—multiple sclerosis	0.000706	0.00275	CcSEcCtD
Mianserin—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000705	0.00274	CcSEcCtD
Mianserin—HTR1A—cerebellum—multiple sclerosis	0.000702	0.00264	CbGeAlD
Mianserin—SLC6A3—brain—multiple sclerosis	0.000701	0.00264	CbGeAlD
Mianserin—Lethargy—Methotrexate—multiple sclerosis	0.0007	0.00273	CcSEcCtD
Mianserin—ADRA2A—medulla oblongata—multiple sclerosis	0.000696	0.00262	CbGeAlD
Mianserin—Feeling abnormal—Azathioprine—multiple sclerosis	0.00069	0.00269	CcSEcCtD
Mianserin—HTR7—central nervous system—multiple sclerosis	0.000687	0.00258	CbGeAlD
Mianserin—HTR1D—brain—multiple sclerosis	0.000684	0.00258	CbGeAlD
Mianserin—Confusional state—Mitoxantrone—multiple sclerosis	0.000682	0.00266	CcSEcCtD
Mianserin—Dizziness—Cladribine—multiple sclerosis	0.000681	0.00265	CcSEcCtD
Mianserin—HTR2C—brain—multiple sclerosis	0.000678	0.00255	CbGeAlD
Mianserin—Oedema—Mitoxantrone—multiple sclerosis	0.000677	0.00264	CcSEcCtD
Mianserin—DRD2—nervous system—multiple sclerosis	0.000674	0.00254	CbGeAlD
Mianserin—HTR7—cerebellum—multiple sclerosis	0.000671	0.00253	CbGeAlD
Mianserin—Eye disorder—Methylprednisolone—multiple sclerosis	0.00067	0.00261	CcSEcCtD
Mianserin—Shock—Mitoxantrone—multiple sclerosis	0.000666	0.00259	CcSEcCtD
Mianserin—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000666	0.00259	CcSEcCtD
Mianserin—Bradycardia—Betamethasone—multiple sclerosis	0.000664	0.00259	CcSEcCtD
Mianserin—Bradycardia—Dexamethasone—multiple sclerosis	0.000664	0.00259	CcSEcCtD
Mianserin—Neutropenia—Prednisone—multiple sclerosis	0.000663	0.00258	CcSEcCtD
Mianserin—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000663	0.00258	CcSEcCtD
Mianserin—Tachycardia—Mitoxantrone—multiple sclerosis	0.000661	0.00257	CcSEcCtD
Mianserin—Skin disorder—Mitoxantrone—multiple sclerosis	0.000657	0.00256	CcSEcCtD
Mianserin—ADRA2C—nervous system—multiple sclerosis	0.000655	0.00247	CbGeAlD
Mianserin—Erectile dysfunction—Prednisone—multiple sclerosis	0.000653	0.00255	CcSEcCtD
Mianserin—Angiopathy—Methylprednisolone—multiple sclerosis	0.000651	0.00253	CcSEcCtD
Mianserin—Rash—Cladribine—multiple sclerosis	0.000649	0.00253	CcSEcCtD
Mianserin—DRD2—central nervous system—multiple sclerosis	0.000649	0.00244	CbGeAlD
Mianserin—Dermatitis—Cladribine—multiple sclerosis	0.000649	0.00253	CcSEcCtD
Mianserin—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000646	0.00252	CcSEcCtD
Mianserin—Weight increased—Prednisone—multiple sclerosis	0.000646	0.00252	CcSEcCtD
Mianserin—Headache—Cladribine—multiple sclerosis	0.000645	0.00251	CcSEcCtD
Mianserin—SLC6A4—brain—multiple sclerosis	0.000642	0.00242	CbGeAlD
Mianserin—HTR2B—brain—multiple sclerosis	0.000637	0.0024	CbGeAlD
Mianserin—ADRA2A—midbrain—multiple sclerosis	0.000636	0.0024	CbGeAlD
Mianserin—DRD2—cerebellum—multiple sclerosis	0.000634	0.00239	CbGeAlD
Mianserin—Hypotension—Mitoxantrone—multiple sclerosis	0.000632	0.00246	CcSEcCtD
Mianserin—ADRA2C—central nervous system—multiple sclerosis	0.000631	0.00238	CbGeAlD
Mianserin—Mental disorder—Methylprednisolone—multiple sclerosis	0.000628	0.00245	CcSEcCtD
Mianserin—ADRA2A—spinal cord—multiple sclerosis	0.000621	0.00234	CbGeAlD
Mianserin—Breast disorder—Methotrexate—multiple sclerosis	0.00062	0.00241	CcSEcCtD
Mianserin—ADRA2C—cerebellum—multiple sclerosis	0.000617	0.00232	CbGeAlD
Mianserin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000617	0.0024	CcSEcCtD
Mianserin—Vertigo—Prednisolone—multiple sclerosis	0.000611	0.00238	CcSEcCtD
Mianserin—Syncope—Prednisolone—multiple sclerosis	0.00061	0.00238	CcSEcCtD
Mianserin—Eye disorder—Dexamethasone—multiple sclerosis	0.000609	0.00237	CcSEcCtD
Mianserin—Eye disorder—Betamethasone—multiple sclerosis	0.000609	0.00237	CcSEcCtD
Mianserin—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000608	0.00237	CcSEcCtD
Mianserin—Somnolence—Mitoxantrone—multiple sclerosis	0.000602	0.00234	CcSEcCtD
Mianserin—Loss of consciousness—Prednisolone—multiple sclerosis	0.000598	0.00233	CcSEcCtD
Mianserin—HTR2A—medulla oblongata—multiple sclerosis	0.000592	0.00223	CbGeAlD
Mianserin—Angiopathy—Betamethasone—multiple sclerosis	0.000592	0.0023	CcSEcCtD
Mianserin—Angiopathy—Dexamethasone—multiple sclerosis	0.000592	0.0023	CcSEcCtD
Mianserin—Convulsion—Prednisolone—multiple sclerosis	0.000589	0.0023	CcSEcCtD
Mianserin—Hypertension—Prednisolone—multiple sclerosis	0.000587	0.00229	CcSEcCtD
Mianserin—Fatigue—Mitoxantrone—multiple sclerosis	0.000583	0.00227	CcSEcCtD
Mianserin—Constipation—Mitoxantrone—multiple sclerosis	0.000579	0.00225	CcSEcCtD
Mianserin—Bradycardia—Prednisone—multiple sclerosis	0.000578	0.00225	CcSEcCtD
Mianserin—HTR1A—brain—multiple sclerosis	0.00057	0.00215	CbGeAlD
Mianserin—SLC6A2—brain—multiple sclerosis	0.000566	0.00213	CbGeAlD
Mianserin—Pancytopenia—Methotrexate—multiple sclerosis	0.000563	0.00219	CcSEcCtD
Mianserin—Vertigo—Triamcinolone—multiple sclerosis	0.000562	0.00219	CcSEcCtD
Mianserin—Syncope—Triamcinolone—multiple sclerosis	0.000561	0.00219	CcSEcCtD
Mianserin—Vertigo—Methylprednisolone—multiple sclerosis	0.000561	0.00218	CcSEcCtD
Mianserin—Syncope—Methylprednisolone—multiple sclerosis	0.00056	0.00218	CcSEcCtD
Mianserin—Connective tissue disorder—Prednisone—multiple sclerosis	0.000558	0.00217	CcSEcCtD
Mianserin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000558	0.00217	CcSEcCtD
Mianserin—Oedema—Prednisolone—multiple sclerosis	0.000555	0.00216	CcSEcCtD
Mianserin—Neutropenia—Methotrexate—multiple sclerosis	0.000554	0.00216	CcSEcCtD
Mianserin—Dizziness—Azathioprine—multiple sclerosis	0.000554	0.00216	CcSEcCtD
Mianserin—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00055	0.00214	CcSEcCtD
Mianserin—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000549	0.00214	CcSEcCtD
Mianserin—Shock—Prednisolone—multiple sclerosis	0.000546	0.00213	CcSEcCtD
Mianserin—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000546	0.00213	CcSEcCtD
Mianserin—CYP2B6—nervous system—multiple sclerosis	0.000545	0.00205	CbGeAlD
Mianserin—HTR7—brain—multiple sclerosis	0.000545	0.00205	CbGeAlD
Mianserin—Convulsion—Triamcinolone—multiple sclerosis	0.000542	0.00211	CcSEcCtD
Mianserin—Tachycardia—Prednisolone—multiple sclerosis	0.000542	0.00211	CcSEcCtD
Mianserin—HTR2A—midbrain—multiple sclerosis	0.000541	0.00204	CbGeAlD
Mianserin—Convulsion—Methylprednisolone—multiple sclerosis	0.000541	0.00211	CcSEcCtD
Mianserin—Hypertension—Triamcinolone—multiple sclerosis	0.00054	0.0021	CcSEcCtD
Mianserin—Hypertension—Methylprednisolone—multiple sclerosis	0.000539	0.0021	CcSEcCtD
Mianserin—Myalgia—Triamcinolone—multiple sclerosis	0.000533	0.00207	CcSEcCtD
Mianserin—HRH1—nervous system—multiple sclerosis	0.000532	0.002	CbGeAlD
Mianserin—Myalgia—Methylprednisolone—multiple sclerosis	0.000531	0.00207	CcSEcCtD
Mianserin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000531	0.00207	CcSEcCtD
Mianserin—Eye disorder—Prednisone—multiple sclerosis	0.000531	0.00207	CcSEcCtD
Mianserin—Drowsiness—Methotrexate—multiple sclerosis	0.000529	0.00206	CcSEcCtD
Mianserin—Rash—Azathioprine—multiple sclerosis	0.000528	0.00206	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000528	0.00206	CcSEcCtD
Mianserin—HTR2A—spinal cord—multiple sclerosis	0.000528	0.00199	CbGeAlD
Mianserin—Dermatitis—Azathioprine—multiple sclerosis	0.000527	0.00205	CcSEcCtD
Mianserin—CYP2B6—central nervous system—multiple sclerosis	0.000525	0.00198	CbGeAlD
Mianserin—Headache—Azathioprine—multiple sclerosis	0.000524	0.00204	CcSEcCtD
Mianserin—ADRA2A—nervous system—multiple sclerosis	0.000523	0.00197	CbGeAlD
Mianserin—Dry mouth—Triamcinolone—multiple sclerosis	0.000521	0.00203	CcSEcCtD
Mianserin—DRD2—brain—multiple sclerosis	0.000515	0.00194	CbGeAlD
Mianserin—Angiopathy—Prednisone—multiple sclerosis	0.000515	0.00201	CcSEcCtD
Mianserin—Confusional state—Methylprednisolone—multiple sclerosis	0.000514	0.002	CcSEcCtD
Mianserin—HRH1—central nervous system—multiple sclerosis	0.000513	0.00193	CbGeAlD
Mianserin—Oedema—Triamcinolone—multiple sclerosis	0.000511	0.00199	CcSEcCtD
Mianserin—Vertigo—Dexamethasone—multiple sclerosis	0.00051	0.00199	CcSEcCtD
Mianserin—Vertigo—Betamethasone—multiple sclerosis	0.00051	0.00199	CcSEcCtD
Mianserin—Syncope—Dexamethasone—multiple sclerosis	0.000509	0.00198	CcSEcCtD
Mianserin—Syncope—Betamethasone—multiple sclerosis	0.000509	0.00198	CcSEcCtD
Mianserin—ADRA2A—central nervous system—multiple sclerosis	0.000504	0.0019	CbGeAlD
Mianserin—Shock—Triamcinolone—multiple sclerosis	0.000502	0.00196	CcSEcCtD
Mianserin—Shock—Methylprednisolone—multiple sclerosis	0.000501	0.00195	CcSEcCtD
Mianserin—ADRA2C—brain—multiple sclerosis	0.000501	0.00189	CbGeAlD
Mianserin—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.0005	0.00195	CcSEcCtD
Mianserin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.0005	0.00195	CcSEcCtD
Mianserin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000499	0.00194	CcSEcCtD
Mianserin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000499	0.00194	CcSEcCtD
Mianserin—Paraesthesia—Prednisolone—multiple sclerosis	0.000499	0.00194	CcSEcCtD
Mianserin—Tachycardia—Triamcinolone—multiple sclerosis	0.000498	0.00194	CcSEcCtD
Mianserin—Mental disorder—Prednisone—multiple sclerosis	0.000498	0.00194	CcSEcCtD
Mianserin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000497	0.00194	CcSEcCtD
Mianserin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000495	0.00193	CcSEcCtD
Mianserin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000493	0.00192	CcSEcCtD
Mianserin—ADRA2A—cerebellum—multiple sclerosis	0.000492	0.00185	CbGeAlD
Mianserin—Convulsion—Dexamethasone—multiple sclerosis	0.000492	0.00192	CcSEcCtD
Mianserin—Convulsion—Betamethasone—multiple sclerosis	0.000492	0.00192	CcSEcCtD
Mianserin—Hypertension—Dexamethasone—multiple sclerosis	0.00049	0.00191	CcSEcCtD
Mianserin—Hypertension—Betamethasone—multiple sclerosis	0.00049	0.00191	CcSEcCtD
Mianserin—Asthenia—Mitoxantrone—multiple sclerosis	0.000486	0.00189	CcSEcCtD
Mianserin—Myalgia—Betamethasone—multiple sclerosis	0.000483	0.00188	CcSEcCtD
Mianserin—Myalgia—Dexamethasone—multiple sclerosis	0.000483	0.00188	CcSEcCtD
Mianserin—Hypotension—Methylprednisolone—multiple sclerosis	0.000476	0.00185	CcSEcCtD
Mianserin—Hepatitis—Methotrexate—multiple sclerosis	0.000475	0.00185	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000465	0.00181	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000464	0.00181	CcSEcCtD
Mianserin—Oedema—Dexamethasone—multiple sclerosis	0.000463	0.0018	CcSEcCtD
Mianserin—Oedema—Betamethasone—multiple sclerosis	0.000463	0.0018	CcSEcCtD
Mianserin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000458	0.00179	CcSEcCtD
Mianserin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000458	0.00178	CcSEcCtD
Mianserin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000457	0.00178	CcSEcCtD
Mianserin—Anaemia—Prednisone—multiple sclerosis	0.000457	0.00178	CcSEcCtD
Mianserin—Shock—Dexamethasone—multiple sclerosis	0.000456	0.00178	CcSEcCtD
Mianserin—Shock—Betamethasone—multiple sclerosis	0.000456	0.00178	CcSEcCtD
Mianserin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000454	0.00177	CcSEcCtD
Mianserin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000454	0.00177	CcSEcCtD
Mianserin—Agitation—Prednisone—multiple sclerosis	0.000454	0.00177	CcSEcCtD
Mianserin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000454	0.00177	CcSEcCtD
Mianserin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000454	0.00177	CcSEcCtD
Mianserin—Tachycardia—Dexamethasone—multiple sclerosis	0.000452	0.00176	CcSEcCtD
Mianserin—Tachycardia—Betamethasone—multiple sclerosis	0.000452	0.00176	CcSEcCtD
Mianserin—HTR2A—nervous system—multiple sclerosis	0.000445	0.00167	CbGeAlD
Mianserin—Vertigo—Prednisone—multiple sclerosis	0.000444	0.00173	CcSEcCtD
Mianserin—Eye disorder—Methotrexate—multiple sclerosis	0.000444	0.00173	CcSEcCtD
Mianserin—Syncope—Prednisone—multiple sclerosis	0.000443	0.00173	CcSEcCtD
Mianserin—Tinnitus—Methotrexate—multiple sclerosis	0.000443	0.00172	CcSEcCtD
Mianserin—Cardiac disorder—Methotrexate—multiple sclerosis	0.00044	0.00172	CcSEcCtD
Mianserin—Fatigue—Triamcinolone—multiple sclerosis	0.00044	0.00171	CcSEcCtD
Mianserin—Fatigue—Methylprednisolone—multiple sclerosis	0.000439	0.00171	CcSEcCtD
Mianserin—Loss of consciousness—Prednisone—multiple sclerosis	0.000435	0.00169	CcSEcCtD
Mianserin—Hypotension—Dexamethasone—multiple sclerosis	0.000433	0.00169	CcSEcCtD
Mianserin—Hypotension—Betamethasone—multiple sclerosis	0.000433	0.00169	CcSEcCtD
Mianserin—Angiopathy—Methotrexate—multiple sclerosis	0.000431	0.00168	CcSEcCtD
Mianserin—Convulsion—Prednisone—multiple sclerosis	0.000428	0.00167	CcSEcCtD
Mianserin—HTR2A—central nervous system—multiple sclerosis	0.000428	0.00161	CbGeAlD
Mianserin—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000428	0.00167	CcSEcCtD
Mianserin—Hypertension—Prednisone—multiple sclerosis	0.000427	0.00166	CcSEcCtD
Mianserin—Rash—Mitoxantrone—multiple sclerosis	0.000427	0.00166	CcSEcCtD
Mianserin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000426	0.00166	CcSEcCtD
Mianserin—Headache—Mitoxantrone—multiple sclerosis	0.000424	0.00165	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000422	0.00164	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000422	0.00164	CcSEcCtD
Mianserin—Myalgia—Prednisone—multiple sclerosis	0.000421	0.00164	CcSEcCtD
Mianserin—Arthralgia—Prednisone—multiple sclerosis	0.000421	0.00164	CcSEcCtD
Mianserin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000421	0.00164	CcSEcCtD
Mianserin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00042	0.00164	CcSEcCtD
Mianserin—HTR2A—cerebellum—multiple sclerosis	0.000418	0.00158	CbGeAlD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000418	0.00163	CcSEcCtD
Mianserin—CYP2B6—brain—multiple sclerosis	0.000417	0.00157	CbGeAlD
Mianserin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000416	0.00162	CcSEcCtD
Mianserin—Paraesthesia—Betamethasone—multiple sclerosis	0.000416	0.00162	CcSEcCtD
Mianserin—Mental disorder—Methotrexate—multiple sclerosis	0.000416	0.00162	CcSEcCtD
Mianserin—CYP3A4—nervous system—multiple sclerosis	0.000412	0.00155	CbGeAlD
Mianserin—HRH1—brain—multiple sclerosis	0.000407	0.00153	CbGeAlD
Mianserin—CYP2D6—nervous system—multiple sclerosis	0.000405	0.00153	CbGeAlD
Mianserin—Oedema—Prednisone—multiple sclerosis	0.000403	0.00157	CcSEcCtD
Mianserin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.0004	0.00156	CcSEcCtD
Mianserin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.0004	0.00156	CcSEcCtD
Mianserin—ADRA2A—brain—multiple sclerosis	0.0004	0.00151	CbGeAlD
Mianserin—Fatigue—Betamethasone—multiple sclerosis	0.000399	0.00156	CcSEcCtD
Mianserin—Fatigue—Dexamethasone—multiple sclerosis	0.000399	0.00156	CcSEcCtD
Mianserin—Shock—Prednisone—multiple sclerosis	0.000397	0.00155	CcSEcCtD
Mianserin—CYP3A4—central nervous system—multiple sclerosis	0.000396	0.00149	CbGeAlD
Mianserin—Nervous system disorder—Prednisone—multiple sclerosis	0.000396	0.00154	CcSEcCtD
Mianserin—Tachycardia—Prednisone—multiple sclerosis	0.000394	0.00153	CcSEcCtD
Mianserin—Skin disorder—Prednisone—multiple sclerosis	0.000392	0.00153	CcSEcCtD
Mianserin—CYP2D6—central nervous system—multiple sclerosis	0.00039	0.00147	CbGeAlD
Mianserin—Anaemia—Methotrexate—multiple sclerosis	0.000382	0.00149	CcSEcCtD
Mianserin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000382	0.00149	CcSEcCtD
Mianserin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000382	0.00149	CcSEcCtD
Mianserin—CYP2D6—cerebellum—multiple sclerosis	0.000381	0.00144	CbGeAlD
Mianserin—Vertigo—Methotrexate—multiple sclerosis	0.000371	0.00145	CcSEcCtD
Mianserin—Leukopenia—Methotrexate—multiple sclerosis	0.00037	0.00144	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000368	0.00143	CcSEcCtD
Mianserin—Dizziness—Prednisolone—multiple sclerosis	0.000367	0.00143	CcSEcCtD
Mianserin—Asthenia—Triamcinolone—multiple sclerosis	0.000366	0.00143	CcSEcCtD
Mianserin—Asthenia—Methylprednisolone—multiple sclerosis	0.000366	0.00142	CcSEcCtD
Mianserin—Paraesthesia—Prednisone—multiple sclerosis	0.000362	0.00141	CcSEcCtD
Mianserin—Pruritus—Triamcinolone—multiple sclerosis	0.000361	0.00141	CcSEcCtD
Mianserin—Pruritus—Methylprednisolone—multiple sclerosis	0.00036	0.0014	CcSEcCtD
Mianserin—Convulsion—Methotrexate—multiple sclerosis	0.000358	0.00139	CcSEcCtD
Mianserin—Arthralgia—Methotrexate—multiple sclerosis	0.000352	0.00137	CcSEcCtD
Mianserin—Myalgia—Methotrexate—multiple sclerosis	0.000352	0.00137	CcSEcCtD
Mianserin—Rash—Prednisolone—multiple sclerosis	0.00035	0.00136	CcSEcCtD
Mianserin—Dermatitis—Prednisolone—multiple sclerosis	0.00035	0.00136	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000349	0.00136	CcSEcCtD
Mianserin—Fatigue—Prednisone—multiple sclerosis	0.000348	0.00135	CcSEcCtD
Mianserin—Headache—Prednisolone—multiple sclerosis	0.000348	0.00135	CcSEcCtD
Mianserin—Constipation—Prednisone—multiple sclerosis	0.000345	0.00134	CcSEcCtD
Mianserin—Confusional state—Methotrexate—multiple sclerosis	0.00034	0.00132	CcSEcCtD
Mianserin—HTR2A—brain—multiple sclerosis	0.00034	0.00128	CbGeAlD
Mianserin—Dizziness—Triamcinolone—multiple sclerosis	0.000338	0.00132	CcSEcCtD
Mianserin—Dizziness—Methylprednisolone—multiple sclerosis	0.000337	0.00131	CcSEcCtD
Mianserin—Feeling abnormal—Prednisone—multiple sclerosis	0.000332	0.0013	CcSEcCtD
Mianserin—Asthenia—Dexamethasone—multiple sclerosis	0.000332	0.00129	CcSEcCtD
Mianserin—Asthenia—Betamethasone—multiple sclerosis	0.000332	0.00129	CcSEcCtD
Mianserin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000331	0.00129	CcSEcCtD
Mianserin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00033	0.00129	CcSEcCtD
Mianserin—Pruritus—Betamethasone—multiple sclerosis	0.000328	0.00128	CcSEcCtD
Mianserin—Pruritus—Dexamethasone—multiple sclerosis	0.000328	0.00128	CcSEcCtD
Mianserin—Skin disorder—Methotrexate—multiple sclerosis	0.000328	0.00128	CcSEcCtD
Mianserin—Rash—Triamcinolone—multiple sclerosis	0.000322	0.00125	CcSEcCtD
Mianserin—Dermatitis—Triamcinolone—multiple sclerosis	0.000322	0.00125	CcSEcCtD
Mianserin—Rash—Methylprednisolone—multiple sclerosis	0.000321	0.00125	CcSEcCtD
Mianserin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000321	0.00125	CcSEcCtD
Mianserin—Headache—Triamcinolone—multiple sclerosis	0.00032	0.00125	CcSEcCtD
Mianserin—Headache—Methylprednisolone—multiple sclerosis	0.000319	0.00124	CcSEcCtD
Mianserin—Hypotension—Methotrexate—multiple sclerosis	0.000315	0.00123	CcSEcCtD
Mianserin—CYP2D6—brain—multiple sclerosis	0.00031	0.00117	CbGeAlD
Mianserin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000307	0.0012	CcSEcCtD
Mianserin—Dizziness—Dexamethasone—multiple sclerosis	0.000306	0.00119	CcSEcCtD
Mianserin—Dizziness—Betamethasone—multiple sclerosis	0.000306	0.00119	CcSEcCtD
Mianserin—Paraesthesia—Methotrexate—multiple sclerosis	0.000303	0.00118	CcSEcCtD
Mianserin—Somnolence—Methotrexate—multiple sclerosis	0.0003	0.00117	CcSEcCtD
Mianserin—Rash—Dexamethasone—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Mianserin—Rash—Betamethasone—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Mianserin—Dermatitis—Dexamethasone—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Mianserin—Dermatitis—Betamethasone—multiple sclerosis	0.000292	0.00114	CcSEcCtD
Mianserin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000291	0.00113	CcSEcCtD
Mianserin—Fatigue—Methotrexate—multiple sclerosis	0.000291	0.00113	CcSEcCtD
Mianserin—Headache—Dexamethasone—multiple sclerosis	0.00029	0.00113	CcSEcCtD
Mianserin—Headache—Betamethasone—multiple sclerosis	0.00029	0.00113	CcSEcCtD
Mianserin—Asthenia—Prednisone—multiple sclerosis	0.000289	0.00113	CcSEcCtD
Mianserin—Pruritus—Prednisone—multiple sclerosis	0.000285	0.00111	CcSEcCtD
Mianserin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000278	0.00108	CcSEcCtD
Mianserin—Dizziness—Prednisone—multiple sclerosis	0.000267	0.00104	CcSEcCtD
Mianserin—Rash—Prednisone—multiple sclerosis	0.000254	0.000991	CcSEcCtD
Mianserin—Dermatitis—Prednisone—multiple sclerosis	0.000254	0.00099	CcSEcCtD
Mianserin—Headache—Prednisone—multiple sclerosis	0.000253	0.000985	CcSEcCtD
Mianserin—Asthenia—Methotrexate—multiple sclerosis	0.000242	0.000942	CcSEcCtD
Mianserin—Pruritus—Methotrexate—multiple sclerosis	0.000239	0.000929	CcSEcCtD
Mianserin—Dizziness—Methotrexate—multiple sclerosis	0.000223	0.000869	CcSEcCtD
Mianserin—Rash—Methotrexate—multiple sclerosis	0.000213	0.000828	CcSEcCtD
Mianserin—Dermatitis—Methotrexate—multiple sclerosis	0.000212	0.000827	CcSEcCtD
Mianserin—Headache—Methotrexate—multiple sclerosis	0.000211	0.000823	CcSEcCtD
Mianserin—HRH2—Signaling by GPCR—IL6—multiple sclerosis	1.83e-05	7.26e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—MAPK1—multiple sclerosis	1.83e-05	7.25e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—MAPK1—multiple sclerosis	1.83e-05	7.24e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—MAPK1—multiple sclerosis	1.82e-05	7.2e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.81e-05	7.19e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	1.81e-05	7.17e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.8e-05	7.13e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	1.8e-05	7.13e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CD86—multiple sclerosis	1.79e-05	7.1e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	1.78e-05	7.07e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.77e-05	7.03e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	1.77e-05	7.01e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCL5—multiple sclerosis	1.76e-05	6.99e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CD86—multiple sclerosis	1.76e-05	6.99e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.76e-05	6.98e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CD86—multiple sclerosis	1.76e-05	6.97e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	1.75e-05	6.94e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—POMC—multiple sclerosis	1.74e-05	6.91e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MMP9—multiple sclerosis	1.74e-05	6.91e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	1.74e-05	6.88e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCL5—multiple sclerosis	1.73e-05	6.86e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	1.73e-05	6.84e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	1.72e-05	6.83e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—MYC—multiple sclerosis	1.71e-05	6.79e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	1.71e-05	6.79e-05	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	1.71e-05	6.78e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TGFB1—multiple sclerosis	1.71e-05	6.78e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CD80—multiple sclerosis	1.71e-05	6.77e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	1.71e-05	6.76e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	1.71e-05	6.76e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TYK2—multiple sclerosis	1.7e-05	6.73e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TYK2—multiple sclerosis	1.7e-05	6.72e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	1.68e-05	6.68e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	1.68e-05	6.67e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	1.68e-05	6.66e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—MAPK1—multiple sclerosis	1.68e-05	6.65e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.68e-05	6.64e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.67e-05	6.63e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.67e-05	6.62e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.65e-05	6.53e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.65e-05	6.52e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.64e-05	6.49e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—POMC—multiple sclerosis	1.64e-05	6.49e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.63e-05	6.47e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—POMC—multiple sclerosis	1.62e-05	6.43e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.61e-05	6.37e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.6e-05	6.36e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SPP1—multiple sclerosis	1.6e-05	6.36e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	1.59e-05	6.31e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1.59e-05	6.3e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CCL2—multiple sclerosis	1.59e-05	6.29e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.58e-05	6.26e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.57e-05	6.21e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.56e-05	6.2e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCR5—multiple sclerosis	1.56e-05	6.18e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.55e-05	6.16e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	1.55e-05	6.16e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—STAT3—multiple sclerosis	1.55e-05	6.14e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	1.55e-05	6.14e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—APOE—multiple sclerosis	1.55e-05	6.13e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	1.54e-05	6.11e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.54e-05	6.11e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	1.54e-05	6.09e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.53e-05	6.07e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.53e-05	6.06e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL2—multiple sclerosis	1.53e-05	6.05e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.5e-05	5.95e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—ALB—multiple sclerosis	1.49e-05	5.91e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.49e-05	5.9e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.48e-05	5.87e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1.46e-05	5.81e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.46e-05	5.79e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—APOE—multiple sclerosis	1.45e-05	5.75e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.45e-05	5.73e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TYK2—multiple sclerosis	1.44e-05	5.71e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	1.44e-05	5.71e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MYC—multiple sclerosis	1.44e-05	5.71e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TGFB1—multiple sclerosis	1.44e-05	5.69e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	1.43e-05	5.68e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL2—multiple sclerosis	1.43e-05	5.68e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	1.43e-05	5.65e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.42e-05	5.64e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.42e-05	5.64e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.42e-05	5.63e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.42e-05	5.62e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.41e-05	5.61e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL2—multiple sclerosis	1.41e-05	5.6e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL2—multiple sclerosis	1.41e-05	5.59e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MAPK1—multiple sclerosis	1.41e-05	5.58e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.41e-05	5.58e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL6—multiple sclerosis	1.41e-05	5.57e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL6—multiple sclerosis	1.4e-05	5.56e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.4e-05	5.56e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL2—multiple sclerosis	1.4e-05	5.56e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.4e-05	5.56e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL6—multiple sclerosis	1.4e-05	5.53e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	1.39e-05	5.53e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.39e-05	5.51e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.38e-05	5.48e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.38e-05	5.46e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	1.37e-05	5.42e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	1.36e-05	5.38e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.35e-05	5.37e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.35e-05	5.34e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	1.34e-05	5.31e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MMP9—multiple sclerosis	1.34e-05	5.3e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MMP9—multiple sclerosis	1.34e-05	5.29e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—POMC—multiple sclerosis	1.33e-05	5.27e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	1.33e-05	5.26e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.31e-05	5.19e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.31e-05	5.18e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	1.3e-05	5.16e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.29e-05	5.13e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL2—multiple sclerosis	1.29e-05	5.11e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL6—multiple sclerosis	1.29e-05	5.11e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.29e-05	5.1e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.28e-05	5.09e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	1.28e-05	5.08e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1.26e-05	4.98e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.25e-05	4.95e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—POMC—multiple sclerosis	1.25e-05	4.94e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.24e-05	4.92e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.22e-05	4.84e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	1.22e-05	4.84e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.22e-05	4.83e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.22e-05	4.82e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.21e-05	4.82e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—ALB—multiple sclerosis	1.21e-05	4.8e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	1.21e-05	4.78e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.2e-05	4.75e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.2e-05	4.74e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.19e-05	4.73e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.19e-05	4.73e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.19e-05	4.71e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—STAT3—multiple sclerosis	1.19e-05	4.71e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—STAT3—multiple sclerosis	1.19e-05	4.71e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	1.18e-05	4.67e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.17e-05	4.64e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.17e-05	4.64e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.17e-05	4.63e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ALB—multiple sclerosis	1.14e-05	4.5e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MMP9—multiple sclerosis	1.14e-05	4.5e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MYC—multiple sclerosis	1.12e-05	4.44e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	1.12e-05	4.43e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.11e-05	4.41e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MYC—multiple sclerosis	1.1e-05	4.38e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.1e-05	4.37e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MYC—multiple sclerosis	1.1e-05	4.37e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	1.1e-05	4.37e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	1.1e-05	4.36e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	1.1e-05	4.35e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MYC—multiple sclerosis	1.1e-05	4.34e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.1e-05	4.34e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	1.09e-05	4.33e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.09e-05	4.31e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.09e-05	4.3e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	1.08e-05	4.3e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.08e-05	4.29e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	1.08e-05	4.29e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—multiple sclerosis	1.08e-05	4.29e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	1.08e-05	4.28e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	1.08e-05	4.28e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	1.08e-05	4.27e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	1.07e-05	4.25e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.06e-05	4.22e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL2—multiple sclerosis	1.05e-05	4.14e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	1.04e-05	4.12e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL2—multiple sclerosis	1.04e-05	4.12e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	1.03e-05	4.1e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	1.02e-05	4.06e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	1.01e-05	4.01e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—STAT3—multiple sclerosis	1.01e-05	4e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOE—multiple sclerosis	1.01e-05	4e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MYC—multiple sclerosis	1.01e-05	4e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	1.01e-05	3.99e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	1.01e-05	3.99e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	9.89e-06	3.92e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	9.87e-06	3.91e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	9.86e-06	3.91e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	9.84e-06	3.9e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	9.57e-06	3.79e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MYC—multiple sclerosis	9.38e-06	3.72e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	9.36e-06	3.71e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL2—multiple sclerosis	9.18e-06	3.64e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	9.18e-06	3.64e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—multiple sclerosis	9.13e-06	3.62e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	9.11e-06	3.61e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL2—multiple sclerosis	9.03e-06	3.58e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL2—multiple sclerosis	9.01e-06	3.57e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	8.99e-06	3.56e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—multiple sclerosis	8.97e-06	3.55e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	8.8e-06	3.49e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	8.75e-06	3.47e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—multiple sclerosis	8.69e-06	3.44e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—POMC—multiple sclerosis	8.66e-06	3.43e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	8.55e-06	3.39e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOE—multiple sclerosis	8.54e-06	3.39e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—multiple sclerosis	8.53e-06	3.38e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	8.51e-06	3.37e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	8.47e-06	3.36e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	8.45e-06	3.35e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—multiple sclerosis	8.42e-06	3.34e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—multiple sclerosis	8.3e-06	3.29e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—multiple sclerosis	8.29e-06	3.29e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	8.28e-06	3.28e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—multiple sclerosis	8.24e-06	3.27e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	8.22e-06	3.26e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	8.18e-06	3.24e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MYC—multiple sclerosis	8.17e-06	3.24e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	8.15e-06	3.23e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MYC—multiple sclerosis	8.13e-06	3.22e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	8.11e-06	3.22e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	8e-06	3.17e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	7.96e-06	3.15e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	7.91e-06	3.14e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ALB—multiple sclerosis	7.9e-06	3.13e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	7.89e-06	3.13e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	7.78e-06	3.08e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	7.74e-06	3.07e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—STAT3—multiple sclerosis	7.72e-06	3.06e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	7.6e-06	3.01e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—STAT3—multiple sclerosis	7.58e-06	3.01e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—multiple sclerosis	7.58e-06	3e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—POMC—multiple sclerosis	7.34e-06	2.91e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MYC—multiple sclerosis	7.18e-06	2.84e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	7.16e-06	2.84e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MYC—multiple sclerosis	7.06e-06	2.8e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—multiple sclerosis	7.05e-06	2.79e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MYC—multiple sclerosis	7.05e-06	2.79e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	7.04e-06	2.79e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	7.03e-06	2.79e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	7.02e-06	2.78e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	6.91e-06	2.74e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	6.91e-06	2.74e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	6.89e-06	2.73e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ALB—multiple sclerosis	6.69e-06	2.65e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOE—multiple sclerosis	6.59e-06	2.61e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	6.42e-06	2.55e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	6.41e-06	2.54e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	6.37e-06	2.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	6.29e-06	2.49e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—multiple sclerosis	6.14e-06	2.44e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—multiple sclerosis	6.11e-06	2.42e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	5.95e-06	2.36e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—POMC—multiple sclerosis	5.66e-06	2.24e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—multiple sclerosis	5.4e-06	2.14e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—multiple sclerosis	5.31e-06	2.1e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—multiple sclerosis	5.3e-06	2.1e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ALB—multiple sclerosis	5.16e-06	2.05e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	4.83e-06	1.91e-05	CbGpPWpGaD
